Infectious Bursal Disease (Gumboro Disease)

Infectious Bursal Disease (IBD), also known as Gumboro disease, is an acute, highly contagious viral infection of young chickens caused by the Infectious Bursal Disease Virus (IBDV), a member of the family Birnaviridae. The disease primarily targets the bursa of Fabricius, the central organ of B-lymphocyte development in birds, leading to severe immunosuppression. IBD is of major economic importance to the global poultry industry, affecting broilers, commercial layers, and broiler breeders, with morbidity rates often approaching 100% and mortality ranging from 0% to 30% depending on the virulence of the strain and the immune status of the flock. The disease is characterized by inflammation, necrosis, and subsequent atrophy of the bursa, resulting in a marked reduction in humoral immune responses and increased susceptibility to secondary infections. IBDV exists in two serotypes (1 and 2), with serotype 1 being pathogenic to chickens, and is further classified into classic, variant, and very virulent (vvIBDV) strains based on antigenic and pathogenic characteristics. The disease is distributed worldwide, with vvIBDV strains causing severe outbreaks in Europe, Asia, Africa, and South America, while classic and variant strains are more common in North America. Effective control relies on stringent biosecurity, vaccination of breeders to provide maternal antibodies, and vaccination of young chicks with live attenuated or recombinant vaccines.

The causative agent is Infectious Bursal Disease Virus (IBDV), a non-enveloped, double-stranded RNA virus with a bi-segmented genome (segments A and B). Segment A encodes the viral capsid proteins VP2 and VP3, and the viral protease VP4, while segment B encodes the RNA-dependent RNA polymerase VP1. VP2 is the major host-protective immunogen and contains the antigenic epitopes responsible for neutralizing antibodies and serotype specificity. IBDV is classified into two serotypes: serotype 1, which is pathogenic to chickens and includes classic, variant, and very virulent strains, and serotype 2, which is non-pathogenic to chickens but may infect turkeys. The virus is highly resistant to environmental conditions, including heat (resistant to 60°C for 30 minutes), pH extremes (stable between pH 2 and 12), and many common disinfectants, making biosecurity challenging. The virus is also resistant to ultraviolet light and can persist in poultry houses, litter, feed, water, and equipment for months. The very virulent strains (vvIBDV) are characterized by a distinct amino acid motif in the VP2 protein (e.g., 222A, 242I, 253Q, 256I, 279D, 284A, 294I, 299S) that enhances pathogenicity and allows the virus to escape maternal antibody protection at higher titers. Variant strains, such as Delaware and GLS, have antigenic changes in VP2 that allow them to evade immunity induced by classic strains, leading to subclinical immunosuppression in broilers.

IBD is a highly contagious disease of chickens, with turkeys and ducks being susceptible to infection but typically not showing clinical disease. The disease primarily affects young chickens, with clinical signs most commonly observed in birds aged 3 to 6 weeks, although very virulent strains can cause disease in birds as young as 1 week and as old as 15 weeks. Broilers are particularly affected due to their high stocking density and rapid growth, leading to high morbidity (up to 100%) and mortality (up to 30% in susceptible flocks). Commercial layers and broiler breeders are also at risk, especially if vaccination programs are inadequate, leading to egg production drops and immunosuppression. The virus is transmitted horizontally through the fecal-oral route, with contaminated feed, water, litter, equipment, and personnel serving as fomites. The virus is shed in feces for up to 2 weeks after infection, and the environment remains contaminated for long periods. Vertical transmission does not occur, but the virus can be present in the hatchery if eggs are contaminated. Risk factors include poor biosecurity, high stocking density, inadequate cleaning and disinfection, and the presence of other immunosuppressive agents such as Marek's disease virus, chicken anemia virus, and mycotoxins. Seasonality is not pronounced, but outbreaks may be more common in temperate climates during cooler months when birds are housed indoors. The economic impact includes mortality, reduced weight gain, poor feed conversion ratio (FCR), increased condemnation at processing, and increased susceptibility to secondary infections such as colibacillosis and coccidiosis.

The pathogenesis of IBD begins with oral or respiratory entry of the virus, followed by primary replication in the gut-associated lymphoid tissue (GALT) and macrophages. The virus then spreads via the bloodstream to the bursa of Fabricius, where it selectively infects and destroys actively dividing B-lymphocytes. The bursa is the primary target organ, and the virus replicates in the bursal follicles, causing severe lymphoid necrosis, inflammation, and infiltration of heterophils and macrophages. This leads to bursal enlargement and edema in the acute phase (2-3 days post-infection), followed by atrophy and fibrosis in the recovery phase (7-10 days post-infection). The destruction of B-lymphocytes results in a profound immunosuppression, characterized by reduced serum immunoglobulin levels (especially IgG and IgA), impaired antibody responses to vaccines and pathogens, and increased susceptibility to opportunistic infections. The virus also replicates in other lymphoid tissues, including the thymus, spleen, and cecal tonsils, but to a lesser extent. Very virulent strains cause more extensive lymphoid depletion and may also affect the bone marrow and peripheral blood lymphocytes. The immunosuppression is most severe when infection occurs at a young age (less than 2 weeks), leading to long-lasting immune dysfunction. In addition to immunosuppression, the virus can cause direct damage to the intestinal mucosa, leading to diarrhea and malabsorption. The disease is often exacerbated by concurrent infections, such as infectious bronchitis virus, Mycoplasma gallisepticum, and Escherichia coli, which can increase mortality and morbidity.

Several intrinsic and extrinsic factors predispose flocks to IBD outbreaks. Intrinsic factors include genetic susceptibility, with certain broiler lines being more susceptible to vvIBDV than others. Age is a critical factor, as chicks are most susceptible between 3 and 6 weeks of age, when maternal antibody levels wane. The immune status of the flock is crucial; flocks with inadequate maternal antibody titers or poor vaccination responses are at higher risk. High production stress, such as rapid growth in broilers or peak egg production in layers, can increase susceptibility. Extrinsic factors include poor biosecurity, allowing introduction of the virus through contaminated equipment, vehicles, personnel, or live poultry. High stocking density and poor ventilation lead to increased ammonia levels and respiratory stress, which may enhance viral entry. Wet litter and poor sanitation provide a favorable environment for virus survival. Feed and water contamination with feces can facilitate transmission. Vaccination failures due to improper vaccine storage, administration, or interference from maternal antibodies can leave flocks susceptible. Additionally, the presence of other immunosuppressive agents, such as Marek's disease virus, chicken anemia virus, and mycotoxins (e.g., aflatoxin, ochratoxin), can exacerbate the severity of IBD and impair the immune response to vaccination.

Clinical signs of IBD vary depending on the virulence of the strain and the immune status of the flock. In classic IBD, the incubation period is 2-3 days, and the disease is characterized by a sudden onset of depression, ruffled feathers, anorexia, and watery diarrhea. Birds may huddle together, appear listless, and have soiled vents. The morbidity rate is high (up to 100%), but mortality is usually low (0-5%) in classic strains. In very virulent IBD (vvIBDV), the onset is more acute, with mortality rates reaching 20-30% or higher in susceptible flocks. Birds may show severe prostration, dehydration, and a high fever. In addition to the gastrointestinal signs, respiratory signs such as coughing and sneezing may be observed due to immunosuppression and secondary infections. In layers and breeders, a drop in egg production of 10-30% may occur, along with an increase in the number of soft-shelled and misshapen eggs. Subclinical IBD is common in broilers infected at a young age (less than 2 weeks), where the only signs may be poor growth, unevenness, and increased susceptibility to other diseases. Neurological signs are rare but can occur if the virus spreads to the central nervous system, leading to tremors and paralysis. The clinical course is typically 5-7 days, after which birds may recover, but the immunosuppressive effects can last for several weeks.

Differential diagnoses for IBD include other viral, bacterial, and parasitic diseases that cause similar clinical signs and lesions. Key differentials include: 1) Infectious bronchitis (IB): Causes respiratory signs, tracheal rales, and nephritis in some strains; lesions include tracheitis and swollen kidneys, but bursal lesions are absent. 2) Marek's disease (MD): Causes paralysis, visceral tumors, and nerve enlargement; bursal atrophy may occur but is not the primary lesion. 3) Chicken anemia virus (CAV): Causes anemia, bone marrow aplasia, and immunosuppression; lesions include pale bone marrow and thymic atrophy, but bursal lesions are less prominent. 4) Coccidiosis: Causes bloody diarrhea and intestinal lesions, but bursal lesions are absent; coccidial oocysts are found in fecal smears. 5) Hemorrhagic enteritis (HE) in turkeys: Causes intestinal hemorrhage and splenomegaly, but primarily affects turkeys, not chickens. 6) Newcastle disease (ND): Causes respiratory, nervous, and gastrointestinal signs; lesions include tracheitis, hemorrhagic intestinal lesions, and encephalitis, but bursal lesions are not typical. 7) Avian encephalomyelitis (AE): Causes neurological signs in young chicks, but no bursal lesions. 8) Reovirus infections (viral arthritis/tenosynovitis): Cause lameness and joint swelling, but bursal lesions are absent. 9) Bacterial septicemias (e.g., colibacillosis, salmonellosis): Cause systemic signs and lesions such as peritonitis, hepatitis, and splenomegaly, but bursal lesions are not characteristic. 10) Mycoplasmosis (e.g., Mycoplasma gallisepticum): Causes respiratory signs and airsacculitis, but bursal lesions are absent. Definitive diagnosis relies on detection of IBDV or its antigens in bursal tissue, along with characteristic histopathological lesions.

The diagnostic algorithm for IBD begins with a thorough flock history, including vaccination status, age, and clinical signs. If IBD is suspected, a stepwise approach is recommended: 1) Clinical observation: Note the sudden onset of depression, diarrhea, and high morbidity with variable mortality. 2) Gross necropsy: Examine the bursa of Fabricius for characteristic lesions. In the acute phase (2-3 days post-infection), the bursa is enlarged, edematous, and may have a yellowish, gelatinous appearance. In the recovery phase (7-10 days), the bursa is atrophied and grayish. Also check for petechial hemorrhages in the thigh and breast muscles, and dehydration. 3) Histopathology: Collect bursal tissue in 10% neutral buffered formalin for histopathological examination. Characteristic lesions include lymphoid necrosis, follicular depletion, and infiltration of heterophils and macrophages. 4) Virus detection: Use RT-PCR or real-time RT-PCR on bursal tissue or cloacal swabs to detect IBDV RNA. This is the most sensitive and specific method. 5) Virus isolation: Inoculate bursal homogenates into embryonated chicken eggs via the chorioallantoic membrane (CAM) or into cell cultures (e.g., BGM-70 cells). 6) Serology: Collect serum samples from affected and recovered birds to detect antibodies using ELISA or AGID. A rising antibody titer between acute and convalescent samples confirms infection. 7) Molecular characterization: Sequence the VP2 gene to determine the strain type (classic, variant, or vvIBDV) and assess antigenic relatedness. 8) Rule out other diseases: Perform tests for other immunosuppressive agents (e.g., CAV, MDV) and secondary bacterial infections. The diagnostic algorithm should be completed within 48-72 hours to guide control measures.

Laboratory findings in IBD include: 1) Serology: ELISA is the most common test, and a significant increase in antibody titers (e.g., 4-fold or greater) between acute and convalescent sera indicates infection. In vaccinated flocks, ELISA titers may be high, but a sudden rise suggests field exposure. AGID is also used but is less sensitive. 2) Molecular diagnostics: RT-PCR and real-time RT-PCR are highly sensitive and specific for detecting IBDV RNA in bursal tissue, cloacal swabs, and environmental samples. Real-time RT-PCR can quantify viral load and differentiate strains using melting curve analysis or sequencing. 3) Virus isolation: Isolation in embryonated eggs (CAM route) or cell culture (BGM-70) is confirmatory but time-consuming. 4) Histopathology: Microscopic lesions include lymphoid necrosis in bursal follicles, with depletion of lymphocytes and infiltration of heterophils and macrophages. In severe cases, there may be cystic cavities and fibrosis. 5) Hematology: In acute cases, there may be leukopenia and lymphopenia. 6) Blood chemistry: Dehydration may cause elevated hematocrit and total protein. 7) Fecal examination: Not specific, but may show no coccidial oocysts, helping to rule out coccidiosis. 8) Feed assays: If mycotoxins are suspected, test feed for aflatoxin, ochratoxin, and T-2 toxin levels. 9) Bacterial culture: If secondary infections are present, culture from liver, spleen, or lungs to identify pathogens such as E. coli.

Imaging modalities are not commonly used in the diagnosis of IBD, but they can be helpful in research or in cases with unusual presentations. Radiography may be used to assess the bursa of Fabricius in live birds, but it is not practical in a clinical setting. Ultrasonography can be used to measure bursal size and detect enlargement or atrophy, but it is rarely performed in poultry practice. Gross necropsy photography is essential for documenting lesions and for educational purposes. In the acute phase, the bursa is enlarged, edematous, and may have a yellowish, gelatinous appearance. In the recovery phase, the bursa is atrophied and grayish. Other gross lesions include petechial hemorrhages in the thigh and breast muscles, and dehydration. Imaging is not a primary diagnostic tool for IBD, and diagnosis is based on clinical signs, necropsy, and laboratory tests.

Histopathological examination of the bursa of Fabricius is the gold standard for confirming IBD. In the acute phase (2-3 days post-infection), the bursal follicles show severe lymphoid necrosis, with pyknosis and karyorrhexis of lymphocytes. There is infiltration of heterophils and macrophages, and the interfollicular connective tissue is edematous and hyperemic. The bursal epithelium may be hyperplastic and contain intracytoplasmic inclusion bodies (eosinophilic) in some cases. By 4-5 days post-infection, the follicles are depleted of lymphocytes, and there is cystic dilation of the medullary areas. In the recovery phase (7-10 days), the bursa is atrophied, with fibrosis and loss of follicular architecture. The thymus and spleen may also show lymphoid depletion. In very virulent IBD, the lesions are more severe, with extensive necrosis and hemorrhage. Immunohistochemistry can be used to detect IBDV antigens in bursal tissue, which is useful for confirming the diagnosis. Cytological examination of bursal imprints may show necrotic lymphocytes and macrophages, but histopathology is preferred.

There is no specific antiviral treatment for IBD. Management focuses on supportive care and control of secondary infections. In affected flocks, the following measures are recommended: 1) Supportive therapy: Provide electrolytes, vitamins (especially vitamin A, D3, E, and C), and glucose in drinking water to reduce dehydration and stress. 2) Antibiotics: To prevent or treat secondary bacterial infections, administer broad-spectrum antibiotics such as amoxicillin (10-20 mg/kg body weight orally every 12 hours for 3-5 days) or oxytetracycline (20-30 mg/kg orally every 12 hours for 3-5 days) in drinking water. Enrofloxacin (10 mg/kg orally every 24 hours for 3-5 days) may be used where legal, but its use in poultry is restricted in some countries. 3) Anticoccidials: If coccidiosis is a concern, use amprolium (0.0125% in drinking water for 3-5 days) or toltrazuril (25 mg/L drinking water for 2 days). 4) Biosecurity: Strictly enforce biosecurity measures to prevent spread to other houses. 5) Vaccination: In the face of an outbreak, vaccination of unaffected birds with a live intermediate or intermediate-plus IBD vaccine may be considered, but it is not always effective. 6) Depopulation: In severe outbreaks with high mortality, depopulation may be necessary to prevent further spread. 7) Disinfection: Thoroughly clean and disinfect the house with an effective disinfectant (e.g., formaldehyde, chlorine dioxide, or phenolic compounds) after removal of birds. 8) Withdrawal times: Ensure that all medications are withdrawn according to label instructions to avoid residues in meat or eggs.

The prognosis for IBD depends on the virulence of the strain, the age of the birds, and the immune status of the flock. In classic IBD, the prognosis is generally good, with mortality typically less than 5% and recovery within 5-7 days. However, the immunosuppressive effects can lead to long-term problems, including poor growth, increased susceptibility to other diseases, and reduced vaccine responses. In very virulent IBD, the prognosis is guarded, with mortality rates of 20-30% or higher, especially in susceptible flocks. Birds that survive may have permanent immunosuppression, leading to poor performance and increased condemnation at processing. In layers and breeders, egg production may drop by 10-30% and may not fully recover to pre-outbreak levels. The economic impact can be significant, including direct losses from mortality and reduced performance, as well as costs for treatment and vaccination. With prompt supportive care and good biosecurity, the prognosis can be improved, but the disease can be devastating in unvaccinated or poorly vaccinated flocks.

After an IBD outbreak, a structured follow-up plan is essential to monitor recovery and prevent recurrence. 1) Serological monitoring: Collect serum samples from recovered birds at 2-4 weeks post-outbreak to assess antibody titers. A high and uniform titer indicates good flock immunity. 2) Necropsy surveillance: Perform necropsies on any birds that die to ensure that secondary infections are controlled and that the bursa is returning to normal. 3) Cleaning and disinfection: After depopulation, thoroughly clean and disinfect the house, including all equipment, feeders, and drinkers. Use a disinfectant effective against IBDV, such as formaldehyde or chlorine dioxide. Allow the house to remain empty for at least 2-3 weeks before restocking. 4) Litter management: Remove and dispose of litter properly, as it may be contaminated with the virus. 5) Vaccination program review: Evaluate the vaccination program and adjust it if necessary. In broilers, consider using intermediate or intermediate-plus vaccines at 10-14 days of age, depending on maternal antibody levels. In layers and breeders, ensure that breeders are vaccinated to provide high maternal antibody titers to progeny. 6) Biosecurity audit: Review and strengthen biosecurity protocols to prevent re-introduction of the virus. 7) Pullet rearing: For replacement pullets, ensure that they are vaccinated appropriately and that their immune status is monitored.

Clinical pearls: 1) The bursa of Fabricius is the key organ to examine in any suspected IBD case. In the acute phase, it is enlarged and edematous; in the recovery phase, it is atrophied. 2) IBD should be suspected in any flock with sudden onset of depression, diarrhea, and high morbidity, especially in birds aged 3-6 weeks. 3) Subclinical IBD is common in broilers infected at a young age, leading to poor growth and increased susceptibility to other diseases. 4) Maternal antibodies are crucial for protecting chicks; ensure that breeders are vaccinated to provide high and uniform antibody titers. 5) Very virulent IBD can cause high mortality even in vaccinated flocks if the vaccine strain does not match the field strain. Pitfalls: 1) Do not confuse IBD with other causes of diarrhea and depression, such as coccidiosis or bacterial enteritis. Always examine the bursa. 2) Do not rely solely on clinical signs; confirm the diagnosis with RT-PCR or histopathology. 3) Do not vaccinate birds in the face of an outbreak with a live vaccine if they are already infected, as this can exacerbate the disease. 4) Do not neglect biosecurity; IBDV is highly resistant and can persist in the environment for months. 5) Do not ignore the immunosuppressive effects of IBD; affected flocks are at high risk for secondary infections, so implement appropriate antibiotic therapy and supportive care.

Current drug protocols for IBD focus on supportive care and control of secondary infections. Antibiotics: Amoxicillin (10-20 mg/kg body weight orally every 12 hours for 3-5 days) or oxytetracycline (20-30 mg/kg orally every 12 hours for 3-5 days) in drinking water. Enrofloxacin (10 mg/kg orally every 24 hours for 3-5 days) may be used where legal, but its use in poultry is restricted in some countries. Florfenicol (20-30 mg/kg orally every 24 hours for 3-5 days) is also effective. Anticoccidials: Amprolium (0.0125% in drinking water for 3-5 days) or toltrazuril (25 mg/L drinking water for 2 days). Vitamins and electrolytes: Provide a commercial electrolyte solution with vitamins A, D3, E, and C in drinking water for 3-5 days. Vaccines: Live intermediate or intermediate-plus IBD vaccines (e.g., Bursine-2, IBD-BLEN) are administered via drinking water or eye-drop at 10-14 days of age in broilers, depending on maternal antibody levels. In layers and breeders, live vaccines are given at 2-3 weeks and 6-8 weeks, followed by inactivated vaccines (e.g., BursaVac) at 16-18 weeks. Recombinant vaccines (e.g., Vaxxitek HVT+IBD) are available for in-ovo or subcutaneous administration at hatch. Dosages and withdrawal times should follow manufacturer recommendations and local regulations.

Landmark studies on IBD include: 1) The original description of the disease by Cosgrove in 1962, which identified the clinical and pathological features. 2) Studies by Winterfield and others in the 1970s that characterized the virus and developed live vaccines. 3) The emergence of very virulent IBDV in Europe in the late 1980s, leading to studies on molecular characterization and vaccine efficacy (e.g., van den Berg et al., 1991). 4) Research on variant strains in the United States, which showed that classic vaccines did not protect against these strains (e.g., Rosenberger et al., 1985). 5) Studies on the immunosuppressive effects of IBD, demonstrating increased susceptibility to other diseases and reduced vaccine responses (e.g., Sharma et al., 1989). 6) Meta-analyses of vaccination strategies, comparing live intermediate, intermediate-plus, and recombinant vaccines (e.g., Muller et al., 2012). 7) Consensus guidelines from the World Organisation for Animal Health (WOAH/OIE) and the American Association of Avian Pathologists (AAAP) on diagnosis, prevention, and control of IBD. These guidelines emphasize the importance of biosecurity, vaccination, and monitoring. Recent research focuses on the development of novel vaccines, including virus-like particles and DNA vaccines, and on understanding the molecular mechanisms of virulence and immunosuppression.